CIK 0001175680 · Non-accelerated filer<br>Smaller reporting company
CytoDyn Inc.
Sign in to watch- Ticker
- CYDY
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- May 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 753056237
- Phone
- 360-980-8524
- Business address
- 1111 MAIN STREET, SUITE 660, VANCOUVER, WA, 98660
- Former names
- CYTODYN INC, REXRAY CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-05-01 | Kelly Scott A. Chief Medical Officer | Option exercise | +75,000 | $0.57 | $43K | 1,400,293 |
| 2020-05-01 | Kelly Scott A. Chief Medical Officer | Option exercise | +97,009 | $0.56 | $54K | 1,497,302 |
| 2020-05-01 | Kelly Scott A. Chief Medical Officer | Option exercise | +100,000 | $0.49 | $49K | 1,597,302 |
| 2020-05-01 | Kelly Scott A. Chief Medical Officer | Purchase | +250,000 | $0.57 | $141K | 1,847,302 |
| 2020-05-01 | Kelly Scott A. Chief Medical Officer | Option exercise | +66,666 | $0.52 | $35K | 1,913,968 |
| 2020-05-01 | Kelly Scott A. Chief Medical Officer | Option exercise | +750,000 | $0.39 | $289K | 2,663,968 |
| 2020-05-01 | Kelly Scott A. Chief Medical Officer | Option exercise | +93,750 | $0.39 | $37K | 2,757,718 |
| 2020-05-01 | Kelly Scott A. Chief Medical Officer | Sale | −1,200,000 | $3.26 | $3.9M | 1,557,718 |
| 2020-05-01 | Kelly Scott A. Chief Medical Officer | Option exercise · Nonqualified Option - right to buy | +7,123 | 0 | ||
| 2020-05-01 | Kelly Scott A. Chief Medical Officer | Option exercise · Nonqualified Option - right to buy | +75,000 | 0 | ||
| 2020-05-01 | Kelly Scott A. Chief Medical Officer | Option exercise · Nonqualified Option - right to buy | +97,009 | 0 | ||
| 2020-05-01 | Kelly Scott A. Chief Medical Officer | Option exercise · Nonqualified Option - right to buy | +100,000 | 0 | ||
| 2020-05-01 | Kelly Scott A. Chief Medical Officer | Option exercise · Nonqualified Option - right to buy | +250,000 | 0 | ||
| 2020-05-01 | Kelly Scott A. Chief Medical Officer | Option exercise · Nonqualified Option - right to buy | +66,666 | 33,334 | ||
| 2020-05-01 | Kelly Scott A. Chief Medical Officer | Option exercise · Nonqualified Option - right to buy | +750,000 | 0 | ||
| 2020-05-01 | Kelly Scott A. Chief Medical Officer | Option exercise · Nonqualified Option - right to buy | +93,750 | 0 | ||
| 2020-05-01 | Pourhassan Nader President & CEO | Sale | −1,399,685 | $3.26 | $4.6M | 2,079,062 |
| 2020-04-30 | Pourhassan Nader President & CEO | Option exercise | +200,000 | $0.90 | $180K | 517,417 |
| 2020-04-30 | Pourhassan Nader President & CEO | Option exercise | +325,000 | $0.87 | $283K | 842,417 |
| 2020-04-30 | Pourhassan Nader President & CEO | Option exercise | +152,000 | $0.75 | $114K | 994,417 |
Page 14 of 33 · 652 trades